Tumor Treatment Fields
Showing 26 - 50 of >10,000
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023
Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)
Terminated
- Glioblastoma
- +2 more
- Bevacizumab
- TTFields Therapy
-
La Jolla, California
- +10 more
May 12, 2021
Gastric Cancer, GastroEsophageal Cancer Trial in Hong Kong (NovoTTF-100L(P), Oxaliplatin, Capecitabine)
Unknown status
- Gastric Cancer
- GastroEsophageal Cancer
- NovoTTF-100L(P)
- +3 more
-
Hong Kong, Hong KongQueen Mary Hospital
Jun 24, 2020
Brain Metastases From NSCLC (NSCLC) Trial in Worldwide (NovoTTF-200M device, Best Standard of Care)
Recruiting
- Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
- NovoTTF-200M device
- Best Standard of Care
-
Birmingham, Alabama
- +109 more
Jun 21, 2022
Ovarian Cancer Trial in Worldwide (NovoTTF-100L(O), Paclitaxel)
Active, not recruiting
- Ovarian Cancer
- NovoTTF-100L(O)
- Paclitaxel
-
Phoenix, Arizona
- +118 more
Apr 19, 2022
Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)
Active, not recruiting
- Nonsmall Cell Lung Cancer
- NSCLC
- NovoTTF-200T
- Immune checkpoint inhibitors or docetaxel
-
Birmingham, Alabama
- +123 more
Oct 13, 2022
Pancreas Adenocarcinoma Trial in Worldwide (NovoTTF-100L(P), Gemcitabine, nab paclitaxel)
Recruiting
- Pancreas Adenocarcinoma
- NovoTTF-100L(P)
- +2 more
-
Birmingham, Alabama
- +145 more
Aug 10, 2022
Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
- concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
-
Jerusalem, IsraelShaare Zedek Medical Center
Jan 22, 2023
Pancreatic Cancer, Metastatic Adenocarcinoma Trial in Winston-Salem (Nab paclitaxel, Gemcitabine, TheraBionic)
Not yet recruiting
- Pancreatic Cancer
- Metastatic Adenocarcinoma
- Nab paclitaxel
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Mar 8, 2023
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy
Recruiting
- Glioblastoma
- Tumor samples from patients treated with TTFields at initial diagnosis.
- Tumor samples from patients treated with TTFields at tumor recurrence.
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Feb 9, 2022
Glioblastoma Trial (TTFields)
Not yet recruiting
- Glioblastoma
- TTFields
- (no location specified)
Nov 15, 2023
Unresectable Solid Tumor, Metastatic Cancer Trial in Saint Louis (Proton GRID Radiotherapy)
Not yet recruiting
- Unresectable Solid Tumor
- Metastatic Cancer
- Proton GRID Radiotherapy
-
Saint Louis, MissouriWashington University School of Medicine
Apr 25, 2023
NSCLC Trial in Philadelphia (device, drug, other)
Not yet recruiting
- NSCLC
- Aliya Pulsed Electric Fields (PEF) ablation
- +3 more
-
Philadelphia, PennsylvaniaTemple University
Oct 24, 2022
Glioblastoma Trial in Aarhus C (Optune, Craniectomy)
Completed
- Glioblastoma
- Optune
- Craniectomy
-
Aarhus C, Aarhus, DenmarkAarhus University Hospital
Nov 25, 2019
Brain Metastases Trial in Changsha (ASCLU-300 TTF)
Recruiting
- Brain Metastases
- ASCLU-300 TTF
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Feb 27, 2022
Carcinoma, Transitional Cell Trial in San Francisco (Atezolizumab)
Active, not recruiting
- Carcinoma, Transitional Cell
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 24, 2022
Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)
Active, not recruiting
- Laryngeal Cancer Stage II
- +3 more
- radiotherapy
- Olaparib
-
Amsterdam, NetherlandsThe Netherlands Cancer Institute
Sep 27, 2022
Radiotherapy - Comprehensive Radiobiology Assessment TRial
Not yet recruiting
- Locally Advanced Cervical Carcinoma
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 1, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in Duarte (Megestrol Acetate, Pterostilbene)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma
- Megestrol Acetate
- Pterostilbene
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Low-grade Glioma Trial in San Francisco (ReMind iPad app, Healthy SMS texting, In-person cognitive rehabilitation)
Recruiting
- Low-grade Glioma
- ReMind iPad app
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 16, 2022
Why Still in Neurosurgical Ward After Tumor Craniotomy?
Recruiting
- Surgery--Complications
- Brain Tumor
- No intervention
-
Copenhagen, DenmarkDepartment of Neuroanesthesiology, Rigshospitalet
Aug 16, 2022
Gastric Cancer (Diagnosis) Trial (Modified Banxia Xiexin Decoction, combination chemo with Placebo granules)
Completed
- Gastric Cancer (Diagnosis)
- Modified Banxia Xiexin Decoction
- combination chemotherapy with Placebo granules
- (no location specified)
Jun 16, 2023
Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)
Recruiting
- Multiple Myeloma
- +2 more
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)
Completed
- Prostate Cancer
- 70.2 Gy 3D-CRT/IMRT
- 79.2 Gy 3D-CRT/IMRT
-
Long Beach, California
- +85 more
Dec 27, 2022